Search

Your search keyword '"Sanmartín, Carmen"' showing total 189 results

Search Constraints

Start Over You searched for: Author "Sanmartín, Carmen" Remove constraint Author: "Sanmartín, Carmen"
189 results on '"Sanmartín, Carmen"'

Search Results

151. Molecular descriptors calculation as a tool in the analysis of the antileishmanial activity achieved by two series of diselenide derivatives. An insight into its potential action mechanism.

152. In vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates.

153. A dihydroselenoquinazoline inhibits S6 ribosomal protein signalling, induces apoptosis and inhibits autophagy in MCF-7 cells.

154. Topical treatment of L. major infected BALB/c mice with a novel diselenide chitosan hydrogel formulation.

155. Synthesis and antiproliferative activity of novel methylselenocarbamates.

156. Novel hybrid selenosulfonamides as potent antileishmanial agents.

157. Synthesis and antiproliferative activity of novel selenoester derivatives.

158. Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) – Pluronic® F127 copolymers for controlled protein release.

159. Novel quinazoline and pyrido[2,3-d]pyrimidine derivatives and their hydroselenite salts as antitumoral agents.

160. Synthesis of novel organic selenium compounds and speciation of their metabolites in biofortified kale sprouts.

161. Following the Trace of Cyclodextrins on the Selenium and Tellurium Odyssey.

162. Selenization of Small Molecule Drugs: A New Player on the Board.

163. Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties.

164. Seleno-Warfare against Cancer: Decoding Antitumor Activity of Novel Acylselenoureas and Se-Acylisoselenoureas.

165. Formulation Studies with Cyclodextrins for Novel Selenium NSAID Derivatives.

166. Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity.

167. First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation.

168. Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe 3 O 4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor.

169. Novel Acylselenourea Derivatives: Dual Molecules with Anticancer and Radical Scavenging Activity.

170. Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds.

171. Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects.

172. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments.

173. Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering.

174. Unveiling a New Selenocyanate as a Multitarget Candidate with Anticancer, Antileishmanial and Antibacterial Potential.

175. Seleno-Metabolites and Their Precursors: A New Dawn for Several Illnesses?

176. Novel N , N '-Disubstituted Acylselenoureas as Potential Antioxidant and Cytotoxic Agents.

177. Organoseleno cytostatic derivatives: Autophagic cell death with AMPK and JNK activation.

178. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.

179. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.

180. A diphenyldiselenide derivative induces autophagy via JNK in HTB-54 lung cancer cells.

181. Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.

182. Topological and quantum molecular descriptors as effective tools for analyzing cytotoxic activity achieved by a series of (diselanediyldibenzene-4,1-diylnide)biscarbamate derivatives.

183. Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.

184. Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) - Pluronic(®) F127 copolymers for controlled protein release.

185. Bisacylimidoselenocarbamates cause G2/M arrest associated with the modulation of CDK1 and Chk2 in human breast cancer MCF-7 cells.

186. Kinase regulation by sulfur and selenium containing compounds.

187. Selenium compounds and apoptotic modulation: a new perspective in cancer therapy.

188. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.

189. Molecular symmetry: a structural property frequently present in new cytotoxic and proapoptotic drugs.

Catalog

Books, media, physical & digital resources